Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis

NCT00648141 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondylitis, Ankylosing

Interventions

DRUG: Celecoxib
DRUG: Celecoxib
DRUG: Diclofenac

Sponsor

Pfizer